Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia GlobeNewswire Sep 28, 2024 1:35pm
Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML GlobeNewswire Sep 18, 2024 8:05pm
Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update GlobeNewswire Aug 13, 2024 8:05pm